Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16f939f54a49a87b8883aea264f9301d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-236 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-42 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-128 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-00 |
filingDate |
2015-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab4d2d4b2917de5f9234879c91abc205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a710f021311577e628841f7deb68573f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf1e57c469d4a42274843247d193aa54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_474e7c5431acbad74cef114537e2695a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0b9ef8a525965d6a24f40987b012bd0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c0b84b6cbe13e9eeb394f00377b62e9 |
publicationDate |
2016-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2016005773-A |
titleOfInvention |
Novel heparin and its utilization |
abstract |
The present invention relates to an immobilized bioactive substance that retains a large biological activity after manipulation. The present invention also includes a medical substrate comprising a heparin body bound to the surface of the substrate through at least one heparin molecule, and the bound heparin body is heparinase sensitive. [Selection] Figure 1 |
priorityDate |
2009-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |